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Abstract
In the Lao People’s Democratic Republic (PDR), mumps is not a notiﬁable disease and mumps vaccine is currently not included in the
routine childhood immunization programme. In order to assess the burden of disease, we investigated the seroprevalence of mumps-speciﬁc
IgG antibodies across four provinces. In addition, we genetically characterized mumps viruses from the past 3 years from several outbreaks
and single cases. Blood and/or throat swabs from suspected cases were investigated for speciﬁc IgM antibodies or viral RNA. Mumps cases
occurred between March and November in 2011–2013 and 5- to 15-year-olds were most affected. Four sequences from an outbreak in the
north of Lao PDR in 2011 were identical and belonged to genotype G. Eight sequences from two outbreaks and two individual cases from
2012 and 2013 belonged to genotype J. In addition, sera collected from 2379 healthy infants and school pupils aged between 9 months and
19 years and from pregnant women aged between 16 and 46 years were investigated for mumps-speciﬁc IgG. Overall, 58.2% were positive,
39.5% were negative and the remaining 2.3% were equivocal. The seropositivity increased with age, with the lowest percentage found in
<1-year-old infants (9.1%) and the highest in the cohort of pregnant women (69.2%). More female subjects than male subjects were
seropositive (60.4 vs. 54.9%). There were some differences between the locations. Mumps should be a notiﬁable disease in Lao PDR in
order to get more accurate case numbers and cost estimates for public health-care, and vaccination of children and high-risk groups should
be considered.
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Introduction
Mumps is a vaccine preventable disease caused by mumps
virus (family, Paramyxoviridae; genus, Rubulavirus) with a
subclinical course in up to one-third of all cases. Common
manifestations include parotitis and respiratory symptoms, and
orchitis in postpubertal male subjects [1]. Laboratory diagnosis
relies on detection of speciﬁc IgM antibodies or mumps virus
RNA. Based on 316 nucleotides covering the small hydro-
phobic (SH) gene region, 12 different genotypes of mumps
virus have been proposed with genotypes C, F, G and H
predominating in Asia [1]. In 2012, 120 out of 194 WHO
member states (62%) were using mumps vaccine in their
national immunization schedule [2]. In the Lao People’s
Democratic Republic (PDR), mumps is not a notiﬁable disease
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and mumps vaccine is currently not included in the routine
childhood immunization programme. Except for 2011, when
only 54 cases were recorded by WHO [3], no data exist. In
order to assess the real burden of disease, we investigated the
seroprevalence of mumps-speciﬁc IgG antibodies across four
provinces. In addition, we genetically characterized mumps
viruses from the past 3 years from several outbreaks and
single cases brought to our attention by the National Center
for Laboratory and Epidemiology (NCLE) and medical doctors.
Thus we provide here the ﬁrst comprehensive information
about mumps in Lao PDR as a guide for future public health
decisions.
Materials and Methods
Data concerning the 2011 and 2013 outbreaks and the 2012
outbreaks in Saravane and Champasack province were
collected by NCLE, in collaboration with the WHO Lao
Country Ofﬁce for 2011 data. The data for the 2012 Vientiane
outbreak were obtained from the Vientiane Capital Health
Ofﬁce. Data for the sporadic cases were collected by the
LaoLuxLab of the Institut Pasteur du Lao PDR.
Blood and/or throat swabs were taken during the outbreaks
from some or all clinical cases and from the sporadic cases and
were investigated for mumps-speciﬁc IgM antibodies (Euroim-
mun, L€ubeck, Germany) or viral RNA, respectively. For RNA
positive samples, the 316 nucleotide SH gene region was
ampliﬁed and sequenced and the data were used for phylo-
genetic analyses according to WHO guidelines [1] with MEGA
4 software [4]. The sequences were submitted to GenBank
under accession numbers KF438181-KF438184 and
HG423644-HG423651.
Sera collected from healthy infants and school pupils aged
between 9 months and 19 years and from pregnant women
aged between 16 and 46 years were investigated for
mumps-speciﬁc IgG antibodies using a commercially available
ELISA kit (Euroimmun) according to the manufacturer’s
instructions. Equivocal samples were retested and classiﬁed
according to the second test result as positive, negative or
equivocal. Before blood collection, informed consent was
obtained from all participants or their parents. Data such as
age, sex and location were recorded and used for the
seroprevalence analyses. For the blood collection, four
different locations were selected: Savannakhet city in the
south (participants between 5 and 19 years), Luangprabang
city in the north (participants aged between 9 months and
19 years and pregnant women), Vientiane city (participants
aged <1 year and pregnant women) and Borikhamxay prov-
ince (participants aged between 5 and 19 years), both in the
centre of the country. Fig. 1 was constructed using ArcView
9.3.1 software (Esri, California, USA). Free spatial data were
downloaded from DIVA-GIS (http://www.diva-gis.org/Data).
Ethical approval was given by the ethics committee of Lao
PDR (NECHR 001/2011).
Results
Outbreak 2011 Oudomxay province
Between 10 March and 23 April 2011, a total of 61 suspected
cases (based on sore throat or cervical/mandibular lymph-
adenopathy or parotid swelling), including three deaths, were
investigated in Mokkha village, located in the Hoon district in
Oudomxay province in Northern Lao PDR (Fig. 1). The
majority of the patients were female (n = 32, 52.5%) and
<16 years old (n = 56, 91.8%). The most affected age group
was the 5–9 year olds (n = 26, 42.6%), followed by the 10–
15 year olds (n = 17, 27.9%) and the 1–4 year olds (n = 13,
21.3%). The highest incidence of disease was observed in
week 14 with 28 new mumps cases (Fig. 2a). Two 8-year-old
girls and an 11-year-old boy died during week 12. Besides
lymphadenopathy, headache, malaise or anorexia, also dizzi-
ness, lethargy, muscle pain or paralysis of the extremities
were observed. For two of the three deceased patients,
encephalitis was diagnosed as the cause of death. Mumps-spe-
ciﬁc IgM antibodies were detected in ﬁve out of six sera and
mumps virus RNA was detected in four out of ten throat
swabs. Thus, nine of the 16 patients from whom clinical
specimens were available (56.3%), were laboratory-conﬁrmed
mumps cases. Interestingly, Coxsackievirus A16 was detected
in one of the mumps PCR-positive samples and in one of the
six mumps virus-negative throat swabs (both cases with
disease onset in week 16). Rhinovirus was found in another
mumps PCR-negative throat swab (case with disease onset
also in week 16).
Outbreak 2012 Vientiane capital
Between 20 July and 2 August 2012, 12 mumps cases were
recorded in Donexingxou village in the Sikhottabong district of
Vientiane capital (Fig. 1). Most patients were male (n = 10,
83.3%) and the ages ranged from 4 to 19 years (median
10.5 years). The most affected age group was the 10–15 year
olds (n = 7, 58.3%), followed by the 5–9 year olds (n = 3,
25.0%). Most cases occurred in week 31 (n = 7, 58.3%),
followed by week 30 (n = 3, 25.0%) and week 29 (n = 2,
16.7%) (Fig. 2a). All patients were reported to have fever,
parotitis and headache and ﬁve patients were admitted to the
hospital. Throat swabs were collected from all hospitalized
patients and four of the samples (80.0%) were positive for the
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mumps virus-speciﬁc PCR. All four patients were also IgM
positive.
Outbreak 2012 Saravane province
A total of 32 mumps cases were recorded between 20
October and 29 November 2012 in Saneumnai village in the
Lao-ngam district in Saravane province (Fig. 1). All patients
were reported to have fever, a sore throat and parotitis and
some also suffered from dizziness and fatigue. The patients
were between 1 and 45 years old (mean 12.1 years) and
slightly more male (n = 17, 53.1%) than female subjects were
affected. None of the four collected throat swabs was PCR
positive, but three of the four sera from the same patients
were mumps IgM antibody positive.
Outbreak 2012 Champasack province
Nine mumps cases were observed between 21 and 29
November 2012 in Kadun village in the Mounlapamok
district (n = 1) and in Donhee village in the Champasack
district (n = 8) in Champasack province (Fig. 1). All patients
had parotitis and some reported fever and headaches. Eight
of the patients were pupils aged between 8 and 12 years
(n = 7 female, 87.5%) and one was a 45-year-old male
teacher. None of the nine throat swabs were PCR positive,
but seven out of nine sera were mumps IgM antibody
positive.
Outbreak 2013 Attapeu province
Between 30 April and 4 May 2013 four mumps cases were
noticed among pupils from Nong-Hin village in the Sanamxai
district in Attapeu province (Figs 1 and 2a). The children were
between 7 and 15 years old and two were male and two
female. All patients were hospitalized on 6 May with fever,
headache, sore throat and parotitis. Throat swabs were
collected from all children and two of them were positive by
mumps virus-speciﬁc PCR.
FIG. 1. Map of Lao PDR showing the
different sample collection sites. PV stands
for province and PF for prefecture.
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Individual case 2012 Vientiane capital
On 11 September 2012 a 24-year-old male Lao citizen from
Vientiane capital was clinically diagnosed as having mumps. A
throat swab was collected, which was positive by PCR.
Individual case 2013 Vientiane capital
On 28 June 2013 a 15-year-old girl from Phakhao village,
Vientiane capital, fell ill with mumps-like symptoms. A throat
swab collected on 1 July was positive by PCR.
Overall summary of laboratory investigation and
conﬁrmation
A total of 120 suspected mumps cases observed between 2011
and 2013 were brought to our attention. Sera and/or throat
swabs for laboratory investigation were available from
one-third of them (n = 40). Laboratory conﬁrmation was
achieved for 27 patients, which is 67.5% of all patients
investigated and 22.5% of all suspected cases.
Phylogenetic analysis of the mumps virus sequences
From all mumps virus-positive throat swabs, the 316 nucleo-
tide region of the SH gene was ampliﬁed and sequenced.
Phylogenetic analysis of the sequences identiﬁed four distinct
virus variants (Fig. 3). The sequences from the 2011 outbreak
were all identical and belonged to genotype G. The closest
relatives identiﬁed by BLAST and phylogenetic analyses were
sequences found in Japan between 1999 and 2005 (e.g.
MuV-Yokohama.JPN/05-1), which differed by ﬁve nucleotides
in the 316 nucleotide region of the SH gene. The sequences
from the 2012 and 2013 outbreaks were also all identical, but
belonged to genotype J. Strains found in Thailand in 2008 (e.g.
MuVs/Phang-nga.THA/4.08-14) were the closest relatives and
differed by a single nucleotide in the SH gene region (Fig. 3).
The individual case from 2012 also belonged to genotype J, but
was very distinct from the 2012 and 2013 outbreak strains (12
mutations, genetic distance 3.95%), while the single case from
2013 differed by only one nucleotide from the 2012 outbreak
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FIG. 2. Number of mumps cases
between 2011 and 2013 (a) by
epidemiological week and (b) according
to age and gender.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, O664–O671
CMI H€ubschen et al. High prevalence of mumps in Laos O667
strains. The closest relatives identiﬁed by BLAST were also the
mumps strains found in Thailand in 2008, which differed by 13
nucleotides from the 2012 strain and by two nucleotides from
the 2013 strain.
Seroprevalence data
A total of 2379 sera collected from four different locations
(Luangprabang, n = 896; Borikhamxay, n = 599; Savannakhet,
n = 587; Vientiane, n = 297) were included in the seropre-
valence study (Fig. 1). Overall, 58.2% of the participants were
positive for mumps-speciﬁc IgG antibodies, 39.5% were
negative and the remaining 2.3% were equivocal (Table 1).
The highest seropositivity of 61.2% was found in Luangpra-
bang, the lowest in Vientiane (52.5%). Of the two locations
sampled in Borikhamxay province, Paksane had a consider-
ably higher overall seropositivity than the more rural
Pakkading (68.3% of 303 samples compared with 43.2% of
296 samples).
As expected, the seropositivity increased with age, with the
lowest percentage found in the <1-year-old infants (9.1%) and
the highest in the cohort of pregnant women (69.2%)
(Table 1). The <1-year-old infants and the pregnant women
from Vientiane had higher seropositivity rates than the
corresponding cohorts from Luangprabang (14.3 vs. 4.0% and
71.4 vs. 67.0%). Among the 5–9 and the 10–14-year-old
children, the highest seropositivity was observed in Luangpra-
bang (60.5 and 70.0%) and the lowest in Borikhamxay (42.7 and
61.5%). The highest percentage of seropositives among the
15–19-year-olds was found in Luangprabang and the lowest in
Savannakhet (75.3 vs. 62.3%, Table 1). Overall, more female
than male subjects were seropositive (60.4 vs. 54.9%, p <0.01),
but without the pregnant women, who included many
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FIG. 3. Phylogenetic tree based on 316
nucleotides of the mumps virus SH gene
region and the Kimura 2-parameter model
and the neighbour-joining algorithm. Light
grey dots mark the sequences obtained
from the mumps outbreak in 2011, grey
triangles highlight sequences from the
2012 outbreak and black diamonds show
sequences from the 2013 outbreak. The
grey square and the black triangle mark
the individual cases from 2012 and 2013,
respectively. White dots indicate the
closest relatives of the sequences from
Lao PDR identiﬁed by BLAST.
TABLE 1. Seroprevalence of mumps-speciﬁc IgG antibodies according to geographical location and age group/cohort
Total
Infants
Positive (%)
5–9 year olds
Positive (%)
10–14 year olds
Positive (%)
15–19 year olds
Positive (%)
Pregnant women
Positive (%)N Positive (%) Negative (%) Equivocal (%)
Luangprabang 896 548 (61.2) 329 (36.7) 19 (2.1) 4/100 (4.0) 112/185 (60.5) 149/213 (70.0) 149/198 (75.3) 134/200 (67.0)
Borikhamxay 599 335 (55.9) 244 (40.7) 20 (3.3) / 85/199 (42.7) 123/200 (61.5) 127/200 (63.5) /
Savannakhet 587 346 (58.9) 230 (39.2) 11 (1.9) / 78/166 (47.0) 141/217 (65.0) 127/204 (62.3) /
Vientiane 297 156 (52.5) 136 (45.8) 5 (1.7) 14/98 (14.3) / / / 142/199 (71.4)
Total 2379 1385 (58.2) 939 (39.5) 55 (2.3) 18/198 (9.1) 275/550 (50.0) 413/630 (65.6) 403/602 (66.9) 276/399 (69.2)
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participants older than 19 years, this difference was no longer
statistically signiﬁcant (57.0% vs. 54.9%, p >0.05, Table 2). This
was also the case for all locations except Savannakhet, where a
slightly higher percentage of positives was found among male
subjects (59.9 vs. 58.2%). The biggest gender difference was
observed in infants from Vientiane (8.5% seropositivity in male
infants and 19.6% in female infants, Table 2), but overall only
98 children were recruited.
Discussion
In the present manuscript, we investigate mumps seropreva-
lence amongst almost 2400 infants, school children and
pregnant women from ﬁve different locations in four provinces
and describe all mumps cases and outbreaks between 2011 and
2013 brought to our attention. While northern, central and
southern regions of Lao PDR are represented both in the
seroprevalence study and the case investigations, samples
were mostly from urban settings. The high seroprevalence
detected during this study indicates that Lao PDR sustains
many more cases than were reported here. Nevertheless, our
study is one of the very few comprehensive studies on mumps
in a speciﬁc country and exceptional in the region because it
combines seroprevalence and case investigation data.
Two different genotypes of mumps virus were found:
genotype G in the north (2011) and genotype J in the central
and the southern parts (2012, 2013). As only 12 sequences
were obtained in total, it is unclear to what extent our ﬁndings
are representative for the country. However, genotype J was
found at four different time-points with some sequence
variation and except for the very distinct strain from 2012
all strains were very similar to viruses detected in 2008 in
Thailand. This strongly suggests that this genotype is endemic
in the region. A recent report from Nan Province of Thailand
close to the border with Laos identiﬁed genotype J during a
mumps outbreak in 2010 [5], but the sequences are not
available for comparison. The individual patient from 2012
declared having been in places frequented by tourists during
the incubation period. Thus this distinct genotype J virus could
either be endemic or could have been introduced directly from
a location outside of Lao PDR. Genotype J has been detected
in several countries, including Ireland [6], the UK [7,8], Japan
[9] and Australia [10], but to date the sequences from Thailand
are the most similar to the distinct strain identiﬁed in Lao PDR
in 2012.
Whether genotype G continuously circulates in northern
Lao PDR requires further investigation. As the genotype G
strains differed by ﬁve nucleotides from the most similar
sequences identiﬁed by BLAST, it remains open whether this
variant is endemic in Lao PDR or whether it was introduced
from outside. While no genotype information is available from
Myanmar, genotype F was reported from across the border
with China [11]. During a recent outbreak in Cambodia,
genotype K was detected [12] and the same genotype was
presumably introduced from Vietnam to Canada (GenBank
accession number KF212192), but so far no genotype G was
reported from the neighbouring countries.
Throat swabs for genotype determination were also
collected during mumps outbreaks in the very south of the
country, namely in Saravane and Champasack provinces, but
the swabs were collected very late after onset of disease
(7 days in one case, between 11 and 19 days in all others).
This late collection is probably the main reason why all
samples were PCR negative because viral RNA is known to
be present during disease onset and then to decline over 8–
10 days [1].
Mumps may be found throughout the year in hot climates
[13]. In Lao PDR mumps cases occurred between the
beginning of March and end of November. In contrast to
the other outbreaks, the one from 2011 in the north showed
a large number of cases, the laboratory-conﬁrmed co-circu-
lation of two different enteroviruses and three deaths. The
co-circulation of different viruses, the high level of malnutri-
tion in the area and poor access to healthcare may potentially
explain disease severity and fatal outcome. Two of the
deceased patients reportedly died from encephalitis. Enceph-
alitis is a very rare complication of mumps [1] and may also
occur after enterovirus infections [14,15], but no samples for
laboratory conﬁrmation were available from the deceased
patients.
While in Europe mumps has become a disease of adoles-
cents and young adults [16–20], most mumps cases in Lao PDR
were found among 5–15-year-old children (Fig. 2b), which
corresponds more with the ‘classical’ age range for an
unvaccinated population [13]. In fact, our seroprevalence data
show that there is a considerable increase in seropositivity
between the age groups 5–9 and 10–14 years (Savannakhet
TABLE 2. Seroprevalence of mumps-speciﬁc IgG antibodies
according to geographical location, cohort and gender
Location Cohort
Female Male
N Positive (%) N Positive (%)
Luangprabang Infants/pupils 364 219 (60.2) 332 195 (58.7)
Pregnant women 200 134 (67.0) / /
Borikhamxay Pupils 290 169 (58.3) 309 166 (53.7)
Savannakhet Pupils 335 195 (58.2) 252 151 (59.9)
Vientiane Infants 51 10 (19.6) 47 4 (8.5)
Pregnant women 199 142 (71.4) / /
All All 1439 869 (60.4) 940 516 (54.9)
All without pregnant women 1040 593 (57.0) 940 516 (54.9)
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47.0 and 65.0%, Luangprabang 60.5 and 70.0%, Borikhamxay
42.7 and 61.5%), indicating that many become infected as
pupils.
In other age-stratiﬁed seroprevalence studies in unvacci-
nated populations, seropositivity was often even higher than in
Lao PDR [21–24]. As about 30% of pregnant women are still
susceptible to infection, mumps may be contracted at a wide
age-range in Lao PDR. This is of concern because mumps may
cause foetal loss during the ﬁrst trimester of pregnancy and
adults are more prone to severe disease complications such as
meningitis or orchitis [13].
The seroprevalence study identiﬁed some differences
between the locations. The overall seropositivity rate for
Vientiane is largely biased due to the high proportion of infants
(98/297, 33.0%), because both infants and pregnant women
showed considerably higher rates in Vientiane than in Luang-
prabang, possibly because of the higher population density in
the capital. This may also explain the differences between
Paksane and the more rural Pakkading, where considerable
differences in seroprevalence are observed even in neighbour-
ing districts within the same province. For all age groups of
pupils, the highest seropositivity rates were detected in
Luangprabang, a town highly frequented by foreign tourists.
The mean and median ages within the age groups or cohorts
were not very different and cannot explain differences in
seropositivity between the locations.
As mumps vaccination is currently not included in the
national immunization schedule in Lao PDR, the overall
seropositivity of 58% is due essentially to wild-type infection.
Besides the currently most affected children between 5 and
15 years, adults with professional contact with these children
are particularly at risk of infection. In neighbouring Thailand
many thousands of mumps cases are reported each year
despite vaccination (9901 and 7422 in 2011 and 2012,
respectively) [3]. The high seropositivity rate found during
the present study suggests that a considerable annual number
of mumps cases must occur also in Lao PDR. Although
under-reporting would be likely from remote places, mumps
should be a notiﬁable disease in Lao PDR to get more accurate
case numbers and cost estimates for public healthcare. In this
context, the importance of laboratory-based surveillance will
increase considerably and it will become imperative that
appropriate specimens are collected in a timely manner to not
only conﬁrm clinically suspected cases, but also to obtain
genotype information for molecular epidemiology.
Recently, rubella vaccination has been introduced into the
national immunization programme in combination with mea-
sles vaccine. The cost-beneﬁt of the incremental cost of using
the combined measles, mumps and rubella vaccine should be
carefully assessed.
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